Evidence map›Paper›PMID 35463918›Full record

ArticleLung cancer management2022

Exceptional response to afatinib in a patient with persistent G719A

Amit A Kulkarni, Naomi Fujioka, Lucia Reinhardt, Manish R Patel, Robert A Kratzke

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Lung cancer management, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Amit A KulkarniDepartment of Medicine, Division of Hematology, Oncology & Transplantation, University of Minnesota, MN 55455, USA.ORCID https://orcid.org/0000-0003-1042-8521
Naomi FujiokaDepartment of Medicine, Division of Hematology, Oncology & Transplantation, University of Minnesota, MN 55455, USA.
Lucia ReinhardtDepartment of Medicine, Division of Hematology, Oncology & Transplantation, University of Minnesota, MN 55455, USA.
Manish R PatelDepartment of Medicine, Division of Hematology, Oncology & Transplantation, University of Minnesota, MN 55455, USA.
Robert A KratzkeDepartment of Medicine, Division of Hematology, Oncology & Transplantation, University of Minnesota, MN 55455, USA.
University of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a patient with metastatic NSCLC harboring a compound

Indexed as

afatinibcompound mutationsEGFR mutationliquid biopsymutationsnext-generation sequencingNSCLCosimertinibrare mutationsuncommon tyrosine kinase inhibitors

Identifiers

PMID35463918
PMCPMC9024393
OpenAlexW4224266352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.